Abstract
INTRODUCTION
The transanal approach may be used to effectively excise rectal carcinoma (RC), which is usually found in the lower part of the rectum. Transanal excision of RCs, however, may be associated with poor locoregional control [1, 2] .Therefore, accuracy of preoperative staging is vital in modern rectal cancer management. Magnetic resonance imaging (MRI) to determine the stage of rectal cancer has been shown to be accurate and reproducible [3, 4] . MRI enables planning for primary tumor resection.
Recent development in MRI provides the distingui shment of extramural vascular invasion (EMVI) prior to surgery being performed [5] . EMVI is described as blood vessels invaded by malignant cells surpassing the muscularis propria of rectal cancer [6] . Chand et al [7] showed that EMVI leads to worse survival outcomes [6] . However, the survival rates of patients with an EMVI positive histology varies dramatically, which suggests that this factor does not relate to each individual tumor in terms of the biology or molecular features.
The ideal staging system will evolve from the consideration of them and the correlation of the prognosis with patientspecific tumor biomarkers [8, 9] . Based on previous studies, we hypothesized that the combination of imaging evidence of EMVI and biomolecular factors could provide additional predictive value in clinical practice, especially for nonadvanced cancer patients.
In this study, three candidate proteins were screened in paraffinembedded tissue samples via immunohistochemistry (IHC). When combined with MRIdetected EMVI, this panel could help clinicians determine the prognosis for patients with RC without regional lymph node involvement and distant meta stasis.
MATERIALS AND METHODS

Patients and tissue specimens
This study was approved by the institutional review board of Harbin Medical University, and consent was obtained from all of the patients in written form. Patients with pathologically confirmed rectal adenocarcinoma who were treatmentnaïve were screened in this research, and were examined through preoperative rectal MRI at the Second Afflict Hospital of Harbin Medical University from July 2011 to July 2014. Patients who were found to have a synchronous regional lymph node and/or distant metastases at the initial staging were excluded from the study. All chosen samples were adopted from the crucial cores of histopathologically confirmed carcinomas during the initial surgeries. Two pathologists performed diagnosis on all of the lesions and the findings were reviewed by an expert colorectal cancer pathologist independently; additionally, the stage of tumor was determined according to the system of the International Union Against Cancer.
MRI protocol
The MRI examination of patients with RC was carried out using a 3.0 T Philips Achieva TX (Philips Medical Systems, Holland) system with an 8channel body phased array coil. Each rectal magnetic resonance examination was performed as follows: To decrease the colonic motility, an intramuscular injection of 20 mg of scopolamine butylbromide (Buscopan; Boehringer Ingelheim, Germany) was administered prior to the MRI. Approximately 100120 mL of saline was rectally administered using an enema syringe. Highresolution magnetic resonance images were obtained, including highresolution oblique axial T2weighted turbo spin echo, oblique coronal T2weighted turbo spinecho and sagittal T2weighted turbo spinecho coupled with the following parameters: TE (echo time) 81 ms185 ms, TR (repetition time) 39005600 ms, thickness of 3 mm, spacing of 3 mm, matrix of 256 × 256 to 320 × 320, field of view of 250 × 250 to 199 × 199, and echo train length of 1735.
Image analysis
All magnetic resonance images required at least three abdominal radiologists to analyze the images separately with no clinical information about the patients. The MRI analysis involved tumor morphology, the presence of EMVI, circumferential resection margin, lymph node involvement and tumor stage. The EMVI grading score was adopted from the system proposed by Smith et al [10] . According to this scoring system, scores of 0 to 2 were defined as EMVI negative disease, and scores of 3 and 4 corresponded to EMVIpositive disease. A score of 3 EMVI included a tumor with a vein that did not change its contour and may have only slightly expanded the vessel. A score of 4 EMVI described an irregularly expanded vein, which indicated the vessel wall was invaded. To achieve a consensus agreement, EMVI negative cases were re evaluated together by three abdominal radiologists.
IHC
To select the study samples, we employed a usual histological categorization according to the WHO classification of tumors. A 3-tiered histological grading system played an important role in this research. The tumornodemetastasis stage was evaluated, based on the guideline of the 2002 International Union Against Cancer classification. Monoclonal mouse antihuman cMYC, PCNA and TIMP1 antibodies were introduced from Santa Cruz Biotechnology (United States). The slides were deparaffinized, rehydrated, immersed in 3% hydrogen peroxide solution for 10 min, heated in citrate buffer (pH 6.0) for 25 min at 95 ℃, and cooled for 60 min at room temperature. The slides were washed with PBS (pH 7.4) between each incubation step. Then, the slides were incubated separately with the primary antibodies. Immunoperoxidase staining was performed using the 2step Envision Method (DAKO, Denmark) abiding by the manufacturer's instructions, and visualized with 3,3 9diaminobenzidine tetrachloride (Sigma, United States). Negative controls were slides with no primary antibodies.
Cytoplasm and membrane staining were men surated for the TIMP1 antibody, and cMYC and PCNA staining showed nuclear localization. Two pathologists counted the positive cells. The scores of the results according to the immunohistochemical staining were obtained with the examiners being completely ignorant of any information related to the patient's clinical data. When it comes to clinicopathological association, the researchers applied a 4tiered scoring system (negative to 3+), taking into consideration the proportion of positive cells and staining intensity as represented before [11] .
Statistical analysis
The statistical analyses were carried out via the SPSS software program (standard version 19.0; SPSS, United States). The distinctions between groups were determined according to the MannWhitney U test or the KruskalWallis H test. The correlation among categorical data underwent statistical analysis using the χ 2 test. KaplanMeier curves resulted from the logrank test for survival analyses. The clinical end point in the research, the period from cancer confirmed to death starting at RC or last contact, was overall survival. Multivariate Cox proportional hazards regression analysis served in the detection of independent prognosticators, which had a conspicuous influence on patient survival. A difference was regarded to be significant under the condition that the Pvalue was less than 0.05.
RESULTS
Characteristics of the study population
A total of 329 RC specimens were collected from patients who underwent an operation. The median patient age was 62 years (range, 2182 years), and the subjects included 122 (37.1%) females and 207 (62.9%) males. All patients underwent curative resection with tumorfree margins. Among all patients, 99 underwent adjuvant chemotherapy. All tumors were histologically diagnosed, graded, and grouped as lowly and moderately differentiated (n = 319) or highly differentiated (n = 10). The followup interval ranged from 1 to 58 mo from the date of diagnosis.
MRI findings
There were 53 cases (16.1%) of EMVIpositive RCs on the initial preoperative MRI scans. Of them, 30 patients (56.6%) had an EMVI score of 3, and 23 patients (43.4%) had an EMVI score of 4. Score 3 MRI detected EMVI only occurred in small vessels. Score 4 was only observed in medium and large vessels, which was consistent with previous findings [12] . observed. Immunostaining of the three proteins was low in some samples but strong in others. Repre sentative examples of IHC expression of TIMP1, cMYC, and PCNA performed in the study cohorts are shown in Figure 1 .
Relationships between protein expression and clinicopathologic characteristics
For TIMP1, positive staining was found mainly in the cytoplasm and membrane of the neoplasm cells, and nuclear localization of cMYC and PCNA was generally There were no significant differences concerning age, sex, chemotherapy and tumor location. However, a significant association was detected between the expression levels of PCNA, TIMP1 and pT (P < 0.01; P = 0.045). Moreover, the overexpression of TIMP1 was associated with the histological grading and perineural invasion (P < 0.01; P < 0.01). Table 1 shows the relationships between the clinicopathological features and protein expression levels.
Independent prognostic value of three-protein IHC panel
Due to the fact that it illustrated that the three protein panel and MRIdetected EMVI was of signi ficant predictive value for survival in the long run, multivariate Cox regression analysis was implemented to decide whether these parameters supplied further information of prognosis independent of known clini copathologic features which could affect the prognosis. As summarized in Table 2 , each parameter had a prognostic significance independently (P < 0.05). Additionally, the threeprotein panel displayed greater significance as an independent prognostic factor (HR = 2.110, 95%CI: 1.6312.556, P < 0.01). The panel combined with the EMVI status could rank patients in a more accurate way (P < 0.01) (Figure 2 ).
DISCUSSION
Nowadays, local excision has won growing popularity as a strategy for treating RC in that it removes the necessity for colostomy, lowers the threatening perioperative risks for patients, and ensures optimistic functional outcomes [13, 14] . This surgical procedure, however, requires a thorough analysis of its oncologic risks since standard resection protocols used to eliminate the rectum with its surrounding lymph nodes have gained favorable oncologic results, and are considered as the gold standard [15] . Hence, proper preoperative staging is necessary. However, staging remains challenging owing to the variable accuracy and limitations of imaging. Patientspecific tumor biomarkers could function as a useful aid to present clinicopathologic parameters for risk stratification. This study identified a threeprotein panel for the prognostic assessment of nonadvanced RC patients that could supplement current diagnostic systems. The cMYC protooncogene encodes a transcription factor that has a vital effect on cell proliferation, differentiation, apoptosis, metabolism, and survival [16, 17] . In recent study on adenocarcinoma of the colorectum, patients with a cMYCGCN gain had low rates of survival compared to those without the gain, which was found to be a poor independent prognostic factor [18] . However, the correlation between expression of cMYC in colorectal cancer and prognosis was contradicted in previous studies [1921] . The conflicting results presumably occurred as cMYC expression is controlled by a complicated regulatory pathway, engaging multi interactive activities with other molecules [22] . In the present study, we clarified that c-MYC overexpression determined by IHC solely was significantly linked with higher rates of survival in colorectal cancer patients when evaluated by multivariate analysis.
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PCNA, which is a nonhistamine nuclear protein, has been confirmed to connect with the degree of malignancy, vascular infiltration, distant metastasis and survival [2325] . TIMPs have been proposed to be important inhibitors of tumor invasion of the extracellular matrix based on in vitro and animal studies [26, 27] . Pellegrini et al [28] put forward that, from the phase of preinvasive node to the phase of invasion, detections of serum levels of CEA and TIMP1 in colorectal cancer patients simultaneously could serve as markers for disease progression in prognosis and diagnosis.
It has been established that patients may expe rience a drastically increased risk of distant metastasis, given pathological EMVI at the moment of primary resection [29] . The highresolution MRI provides the preoperative identification of EMVI [30] ; preoperative MRIdetected EMVI status for rectal cancer is a crucial procedure, especially in the screening of patients for neoadjuvant treatment [31] . A microRNA panel has been shown to have considerable clinical value in the early diagnosis of colorectal cancer [32] . Through the current research, we identified a threeprotein prognostic panel independent of clinicopathological features. What's more important, the threeprotein panel combined with MRIdetected EMVI could rank patients into subgroups with diverse prognoses (P < 0.01), which may benefit clinical intervention.
In conclusion, we have identified a threeprotein panel in a considerable number of rectal tissue specimens that determines prognosis with accuracy independent of clinical prognostic parameters, and it has magnificent clinical value for surgical decisionmaking for treating RC.
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Background
Non-advanced rectal cancer (RC) can be treated using various strategies. Accuracy of preoperative staging is vital for modern management of RC. To accurately classify prognostic risks, this study set out to identify a small, clinically applicable immunohistochemistry (IHC) panel that could be combined with magnetic resonance imaging (MRI)-detected extramural vascular invasion (EMVI) for preoperative prognostic assessment of RC patients.
Research frontiers
MRI is important for the local staging of rectal cancer, the patients who showed MRI-detected EMVI positivity had worse survival outcomes than the EMVInegative cases. Few prior reports contain analyses of the combination of imaging evidence of EMVI and biomolecular factors in RC. The results of this study suggest that the three-protein panel of c-MYC, PCNA and TIMP1 combined with MRI-detected EMVI could provide additional prognostic information for preoperative treatment of RC.
Innovations and breakthroughs
In this study, c-MYC, PCNA and TIMP1 were detected with high expression in 35.9%, 23.7% and 58.7% of tumors, respectively. Significant associations were found between the expression of these proteins and the prognosis (P = 0.032, 
